Earningsreport

Q3/2024 12/31/2023 EPS 82.680 ZacksConsensus 0.870 ActVsEst 81.810 - Beat

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors